| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |